The human dopamine transporter gene: Gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders

European Neuropsychopharmacology

Volumn 11, Issue 6, 2001, Pages 449-455

  Bannon, Michael J ^a   Michelhaugh, Sharon K ^a   Wang, Jun ^a   Sacchetti, Paola ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Gene polymorphisms; Neuron restrictive silencer; nurr1; Transcriptional regulation; Variable number tandem repeat

Indexed keywords

DOPAMINE TRANSPORTER;

ALLELE; ARTICLE; DOPAMINERGIC TRANSMISSION; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; HUMAN; MENTAL DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VARIABLE NUMBER OF TANDEM REPEAT;

ANIMALS; BASE SEQUENCE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE ORDER; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0034748234     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00122-5     Document Type: Article

References (41)

1. Neurotransmitter transporters as molecular targets for addictive drugs
2. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age
3. The dopamine transporter: potential involvement in neuropsychiatric disorders
4. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon
5. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the nurr1 gene
6. Structure and function of the dopamine transporter
7. Association of attention-deficit disorder and the dopamine transporter gene
8. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
9. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures
10. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells
11. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
12. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter
13. The coregulator exchange in transcriptional functions of nuclear receptors
14. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)
15. Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease
16. Genotype influences in vivo dopamine transporter availability in human striatum
17. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients
18. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease
19. Structure and organization of the gene encoding human dopamine transporter
20. Intronic sequences are involved in neural targeting of human dopamine transporter gene expression
21. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo
22. Neurotensin-SPDP-poly-L-lysine conjugate: a non-viral vector for targeted gene delivery to neural cells
23. A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease
24. Differential regulation of transcription by the NURR1/NUR77 subfamily of nuclear transcription factors
25. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators
26. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size
27. The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample
28. Characterization of the 5′-flanking region of the human dopamine transporter gene
29. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism
30. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons
31. Identification of potential target genes for the neuron-restrictive silencer factor
32. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos
33. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy
34. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
35. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations
36. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity
37. Identification of the DNA binding site for NGFI-B by genetic selection in yeast
38. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response
39. Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization
40. Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1
41. Dopamine neuron agenesis in Nurr1-deficient mice